Arbutus Biopharma Corp
ABUS
Loading quote...
Financials
| 52Week High | 4.73 | 52Week Low | 2.71 |
| Beta | 1.06 | Current Ratio Annual | 8.15 |
| Current Ratio Quarterly | 20.53 | Market Cap | 635.48M |
| Net Profit Margin TTM | -351.92 | Operating Margin TTM | -386.51 |
| Price To Book | 7.66 | Price To Free Cash Flow TTM | 30.94 |
| Price To Sales TTM | 41.22 | Quick Ratio Annual | 8.01 |
| Quick Ratio Quarterly | 19.74 | Return On Assets TTM | -44.07 |
| Return On Equity TTM | -59.23 | Return On Investment TTM | -59.23 |
| Revenue Growth3Y | -17.50 | Revenue Growth5Y | 0.53 |
| Revenue Growth Quarterly Yoy | 522.19 | Revenue Growth TTMYoy | 53.19 |
| Revenue Per Share TTM | 0.08 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 156 | 0 | 0 | 5 | 4 | 1 | 105.39M | $342.93M |
| Mar 31, 2025 | 171(+10%) | 24(+%) | 9(+%) | 47(+840%) | 51(+1175%) | 43(+4200%) | 113.26M(+7%) | $393.58M(+15%) |
| Jun 30, 2025 | 164(-4%) | 12(-50%) | 18(+100%) | 66(+40%) | 43(-16%) | 39(-9%) | 95.40M(-16%) | $293M(-26%) |